ViaDerma Inc (VDRM)

[BesaoT35]

Patent valued at $2950 on the balance sheet. I did not know that VDRM had a patent. The marketing talks about a patent pending. There was also a license paid or royalty paid for the transdermal technology.

There is $600,000 in convertible notes due and are in default. And yet new financing keeps emerging. To pay this off through sale of shares, it would tank the stock price to triple zeros. If VDRM were to have a run up in price it would be easier to pay off toxic debt.

If people see this as a fraud, then the stock price will never run up. Only credible good news can save this company and my investment here. New products and increased sales would help a lot here.